Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May 11;381(9878):1663-71.
doi: 10.1016/S0140-6736(13)60989-7.

Bipolar disorder diagnosis: challenges and future directions

Affiliations
Review

Bipolar disorder diagnosis: challenges and future directions

Mary L Phillips et al. Lancet. .

Abstract

Bipolar disorder refers to a group of affective disorders, which together are characterised by depressive and manic or hypomanic episodes. These disorders include: bipolar disorder type I (depressive and manic episodes: this disorder can be diagnosed on the basis of one manic episode); bipolar disorder type II (depressive and hypomanic episodes); cyclothymic disorder (hypomanic and depressive symptoms that do not meet criteria for depressive episodes); and bipolar disorder not otherwise specified (depressive and hypomanic-like symptoms that do not meet the diagnostic criteria for any of the aforementioned disorders). Bipolar disorder type II is especially difficult to diagnose accurately because of the difficulty in differentiation of this disorder from recurrent unipolar depression (recurrent depressive episodes) in depressed patients. The identification of objective biomarkers that represent pathophysiologic processes that differ between bipolar disorder and unipolar depression can both inform bipolar disorder diagnosis and provide biological targets for the development of new and personalised treatments. Neuroimaging studies could help the identification of biomarkers that differentiate bipolar disorder from unipolar depression, but the problem in detection of a clear boundary between these disorders suggests that they might be better represented as a continuum of affective disorders. Innovative combinations of neuroimaging and pattern recognition approaches can identify individual patterns of neural structure and function that accurately ascertain where a patient might lie on a behavioural scale. Ultimately, an integrative approach, with several biological measurements using different scales, could yield patterns of biomarkers (biosignatures) to help identify biological targets for personalised and new treatments for all affective disorders.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

We declare that we have no conflicts of interest.

Figures

Figure 1
Figure 1. Mood changes over time in bipolar disorder type I, bipolar disorder type II, and recurrent unipolar depressive disorder
M=mania. m=hypomania. D=depression.
Figure 2
Figure 2. Conventional diagnostic classification criteria for affective disorders compared with neurobiologically defined classes of illness
(A) Conventional and overlapping diagnostic categories of affective disorders: bipolar disorder type I, bipolar disorder type II, cyclothymia, bipolar disorder not otherwise specified, and recurrent unipolar depressive disorder. The diagnostic criteria for these disorders are based on observable symptoms and mood episodes. (B) Examples of an integrated biological systems approach to affective disorders. New neurobiologically defined classes of affective disorders could be based on biosignatures of dimensions of pathology expressed at genetic, molecular, neural circuitry, and behavioural levels.

References

    1. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry. 2005;186:364–66. - PubMed
    1. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128. - PMC - PubMed
    1. Goodwin FK, Jamison KR, Ghaemi SN. Manic-depressive illness: bipolar disorders and recurrent depression. 2. New York: Oxford University Press; 2007.
    1. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come?. Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161–74. - PubMed